Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for GADOBUTROL
- A Study to Compare How Well Gadoquatrane Works and Its Safety With an Already Available Contrast Agent for MRI in People With Any Known or Suspected Problems of the Body (Except Brain or Spinal Cord-related Problems)
- A Study to Compare How Well Gadoquatrane Works and Its Safety With an Already Available Contrast Agent for MRI in People With Known or Suspected Brain or Spinal Cord-related Problems
- Phenotyping Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS) by Intravesical Contrast Enhanced - Magnetic Resonance Imaging (ICE-MRI) Bladder Permeability Assay
- PSMA-Targeted 18F-DCFPyL PET/MRI for the Detection of Prostate Cancer
- Novel Imaging Technique to Assess Cervical Cancer
- Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years
- Virtual Histology of the Bladder Wall for Bladder Cancer Staging
- Study to Find the Appropriate Dose of a New Gadolinium-based Contrast Agent (GBCA) for Adults Undergoing Magnetic Resonance Imaging (MRI) for Known or Highly Suspected Brain and/or Spinal Cord Conditions
- PET/MRI Scan for the Evaluation of Resectable Stage IA1-IB3 Cervical Cancer
- Novel MRI Techniques for the Characterization and Treatment Assessment of High Grade Brain Lesions
- Efficacy and Safety of Gadopiclenol for Central Nervous System (CNS) Magnetic Resonance Imaging (MRI)
- Efficacy and Safety of Gadopiclenol for Body Magnetic Resonance Imaging (MRI)
- Dotarem vs Gadobutrol Contrast for Breast MRI
- Comparison of Gadovist 75% Standard Dose to Dotarem at Full Standard Dose
- Staging Prostate Cancer With Hybrid C11-Choline PET/MR and mpMRI
- Efficacy of Dotarem® (Gd-DOTA) Versus Gadovist® (Gd-DO3A-butrol) for Late Gadolinium Enhancement Cardiac Magnetic Resonance
- Gadobutrol Versus Gadopentetate Dimeglumine or Gadobenate Dimeglumine Before DCE-MRI in Diagnosing Patients With Multiple Sclerosis, Grade II-IV Glioma, or Brain Metastases
- CEST- Glucose Enhanced MRI for Metastatic Brain Tumours
- Validation of the Efficacy of the Tool GIMIAS® for the Assessment of Left Atrial Fibrosis in a Group of Healthy Volunteers (RESTORE-HV)
- Contrast-enhanced MRI in Detecting Benign and Malignant Liver Lesions
- Functional Magnetic Resonance Imaging of Pancreatic Cancer: a Feasibility and Reproducibility Study
- The Role of the Tumor Microenvironment of Pancreatic Cancer to Predict Treatment Outcome
- Gadobutrol / Gadavist-enhanced Cardiac Magnetic Resonance Imaging (CMRI) to Detect Coronary Artery Disease (CAD)
- Gadobutrol/Gadavist-enhanced Cardiac Magnetic Resonance Imaging (CMRI) to Detect Coronary Artery Disease (CAD)
- Safety and Efficacy of Gadobutrol 1.0 Molar in Japanese Subjects for CNS Imaging
- Comparison of Prohance® With Gadovist®/Gadavist™ in Magnetic Resonance Imaging (MRI) of the Brain
- Gadobutrol Pharmacokinetic and Safety Study in Pediatric Subjects Aged <2 Years (Term Newborn Infants to Toddlers 23 Months of Age Inclusive)
- Gadobutrol Enhanced MRA of the Renal Arteries
- Gadobutrol Enhanced MRA of the Supra-aortic Vessels
- Efficacy and Safety of Gadobutrol 1.0 Molar (Gadovist) for Breast Magnetic Resonance Imaging (MRI)
- Efficacy and Safety of Gadobutrol 1.0 Molar (Gadovist) for Breast MRI
- Gadobutrol Magnevist-controlled Body Study
- Efficacy Evaluation of Dotarem Compared to Gadovist in the Diagnosis of Peripheral Arterial Disease
- Observational Study on the Safety and Tolerability of Gadobutrol (Gadovist) Among Filipino Patients in Magnetic Resonance Imaging
- Dose Finding Study of Gadavist in Central Nervous System (CNS) Magnetic Resonance Imaging (MRI)
- Contrast Enhanced MRI of the CNS - Patients With Known Cerebral Neoplastic Lesions.
- Safety and Efficacy of Gadobutrol 1.0 Molar (Gadavist) in Patients for Central Nervous System (CNS) Imaging
- Safety and Efficacy of Gadobutrol 1.0 Molar ( Gadavist ) in Patients for Central Nervous System (CNS) Imaging
- SH L 562BB Phase II/III Dose Justification and Gadoteridol-controlled Comparative Study
- Efficacy and Safety Study to Evaluate Gadavist (Gadobutrol) as Contrast Agent in Magnetic Resonance Imaging (MRI) of Vascular Diseases in Chinese Patients
- Efficacy and Safety Study to Evaluate Gadavist (Gadobutrol) as Contrast Agent in Magnetic Resonance Imaging (MRI) of Brain or Spine Diseases in Chinese Patients
- Combined 18F-NaF/18F-FDG PET/MRI for Detection of Skeletal Metastases
Clinical trials list
click for details